MedTrace Logo

Costs, Effectiveness, QALYs, and Efficiency of Bioabsorbable Devices in Daily Clinical Practice

NCT02854007 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2016-08-03

No results posted yet for this study

Summary

A multicenter, prospective, observational cohort study with clinical, quality of life, and economic evaluation to ascertain the quality-adjusted life years (QALYs) gained by patients with ischemic heart disease revascularized with Absorb in standard clinical practice in Spain. A before-after comparative analysis will be performed, so that each patient will act as his/her own control.

Conditions

  • Coronary Stenosis Treated With Implant of Bioresorbable Devices

Interventions

DEVICE

Coronary angioplasty with implant of bioresorbable device

Percutaneous coronary intervention

Sponsors & Collaborators

  • Sección Hemodinamica y Cardiologia Intervencionista

    lead OTHER

Principal Investigators

  • Felipe Hernandez, MD · Hospital 12 de Octubre, Madrid

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2016-12-31
Completion
2017-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02854007 on ClinicalTrials.gov